NAD+ Decline in Menopause: Real Biology, Thin Human Evidence So Far
- Design
- —
- Participants
- N/A
- Duration
- —
- Funding
- —
This review suggests NAD+ boosters remain unproven for menopausal health despite promising lab results.
NAD+ is the molecule your cells use to make energy and repair DNA, and levels drop as you age. This review looks specifically at menopause, when falling estrogen adds mitochondrial problems, inflammation and oxidative stress on top of normal aging. Precursors like NMN and nicotinamide riboside (NR) look good in lab and animal work. In people, results vary a lot and long-term safety data are still missing.
Disclaimer: Research summaries are provided for informational purposes only and do not constitute medical advice. Always consult a qualified healthcare professional before making changes to your health routine.
Related Studies
All researchA Common Flame Retardant Made Alcohol Damage Worse, and NAD+ Reversed It
Zebrafish exposed to DBDPE, a flame retardant found in furniture and electronics, handled an alcohol hit much worse than usual.
Why Low NAD+ May Push Insulin-Making Cells Into Self-Inflicted Inflammation
In cells and animals, oxidative stress drained NAD+ inside the insulin-producing cells of the pancreas, flipping a chemical switch that set…
NR May Slow Muscle Aging Clocks While Hard Interval Training Speeds Some Up
Nicotinamide riboside, a popular NAD+ booster, was linked to slower epigenetic aging in muscle across several aging clocks.